Avanos Medical (AVNS) Free Cash Flow (QoQ) (2014 - 2026)
Avanos Medical (AVNS) Free Cash Flow (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -132.36% |
| Dec 31, 2025 | 632.86% |
| Sep 30, 2025 | 266.67% |
| Jun 30, 2025 | -122.11% |
| Mar 31, 2025 | -70.90% |
| Dec 31, 2024 | 226.50% |
| Sep 30, 2024 | -8.68% |
| Jun 30, 2024 | 280.99% |
| Mar 31, 2024 | -277.94% |
| Dec 31, 2023 | -73.02% |
| Sep 30, 2023 | 481.82% |
| Jun 30, 2023 | 38.89% |
| Mar 31, 2023 | -124.43% |
| Dec 31, 2022 | 91.34% |
| Sep 30, 2022 | 0.87% |
| Jun 30, 2022 | 815.63% |
| Mar 31, 2022 | -106.75% |
| Dec 31, 2021 | 157.61% |
| Sep 30, 2021 | 93.68% |
| Jun 30, 2021 | 205.56% |